托法替布治疗低补体血症性荨麻疹性血管炎一例

A Case of Hypocomplementemic Urticarial Vasculitis Treated with Tofacitinib

  • 摘要: 低补体血症性荨麻疹性血管炎(hypocomplementemic urticarial vasculitis,HUV)是一种罕见的自身免疫性疾病,以反复荨麻疹样皮疹、低补体血症和系统受累为特征。该病易被误诊,系统表现可包括关节炎、腹痛、肾脏受累及慢性阻塞性肺疾病等。本文报道1例HUV患者,临床表现为反复腹痛、周身风团及关节痛,实验室检查示补体水平降低,皮肤组织病理符合白细胞碎裂性血管炎,影像学检查提示脊柱关节炎,最终确诊为HUV。患者初始予系统糖皮质激素联合秋水仙碱治疗,但皮疹及关节痛仍有反复,后加用托法替布(属于Janus激酶抑制剂)、甲氨蝶呤治疗,症状得到缓解。本病例提示托法替布对于糖皮质激素治疗效果不佳的低补体血症性荨麻疹性血管炎,可作为一种潜在的治疗选择。

     

    Abstract: Hypocomplementemic urticarial vasculitis (HUV) is a rare autoimmune disorder characterized by recurrent urticarial eruptions, hypocomplementemia and systemic involvement. This disease is prone to misdiagnosis, and its systemic manifestations may include arthritis, abdominal pain, renal involvement, chronic obstructive pulmonary disease and so on. Herein, we report a case of HUV presenting with recurrent abdominal pain, generalized wheals and arthralgia. Laboratory tests revealed decreased complement levels, skin histopathology was consistent with leukocytoclastic vasculitis, and imaging examinations indicated spondyloarthritis, thus confirming the diagnosis of HUV. The patient initially received systemic glucocorticoids combined with colchicine, whereas recurrent rash and arthralgia persisted. Tofacitinib (a Janus kinase inhibitor) and methotrexate were subsequently added to the regimen, leading to remission of symptoms. This case suggests that tofacitinib may serve as a potential therapeutic alternative for patients with HUV who respond poorly to glucocorticoids.

     

/

返回文章
返回